免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

臨床試驗

Capillary Blood Accuracy

NCT:NCT06544070 · WITHDRAWN

NCT IDNCT06544070
狀態WITHDRAWN
開始日期2024-11-04
完成時間2025-11-03
SponsorEntia Ltd (INDUSTRY)
First posted
Last updated

簡要摘要

Entia is a health technology company that has developed a blood testing device called Entia Liberty, which analyses blood collected by a finger prick. Entia is sponsoring this research study to compare the results from Entia Liberty finger prick tests to results from the gold-standard laboratory analyser that tests blood from the arm, port, or PICC line.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。

↑